These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 21577323

  • 1. Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.
    Alseraye FM, Zuo Z, Bueso-Ramos C, Wang S, Medeiros LJ, Lu G.
    Int J Clin Exp Pathol; 2011 Apr; 4(4):371-7. PubMed ID: 21577323
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features.
    Wang SA, Jabbar K, Lu G, Chen SS, Galili N, Vega F, Jones D, Raza A, Kantarjian H, Garcia-Manero G, McDonnell TJ, Medeiros LJ.
    Leukemia; 2010 Apr; 24(4):740-7. PubMed ID: 20072149
    [Abstract] [Full Text] [Related]

  • 4. [C-kit, NPM1 and FLT3 gene mutation patterns and their prognostic significance in 656 Chinese patients with acute myeloid leukemia].
    Ding ZX, Shen HJ, Miao JC, Chen SN, Qiu QC, Qi XF, Jin ZM, Wu DP, He J.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):829-34. PubMed ID: 23384905
    [Abstract] [Full Text] [Related]

  • 5. [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].
    Li L, Lyu XD, Mi RH, Ding J, Chen L, Wang Q, Yin QS, Hu JY, Fan RH, Wei XD.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):601-6. PubMed ID: 23815906
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China.
    Gou H, Zhou J, Ye Y, Hu X, Shang M, Zhang J, Zhao Z, Peng W, Zhou Y, Zhou Y, Song X, Lu X, Ying B.
    Tumour Biol; 2016 Jun; 37(6):7357-70. PubMed ID: 26676635
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
    Paschka P, Du J, Schlenk RF, Gaidzik VI, Bullinger L, Corbacioglu A, Späth D, Kayser S, Schlegelberger B, Krauter J, Ganser A, Köhne CH, Held G, von Lilienfeld-Toal M, Kirchen H, Rummel M, Götze K, Horst HA, Ringhoffer M, Lübbert M, Wattad M, Salih HR, Kündgen A, Döhner H, Döhner K.
    Blood; 2013 Jan 03; 121(1):170-7. PubMed ID: 23115274
    [Abstract] [Full Text] [Related]

  • 11. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A, Luthra R, Medeiros LJ, Zuo Z.
    Am J Clin Pathol; 2011 Jan 03; 135(1):62-9. PubMed ID: 21173125
    [Abstract] [Full Text] [Related]

  • 12. Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation.
    Chen W, Konoplev S, Medeiros LJ, Koeppen H, Leventaki V, Vadhan-Raj S, Jones D, Kantarjian HM, Falini B, Bueso-Ramos CE.
    Cancer; 2009 Dec 01; 115(23):5481-9. PubMed ID: 19672946
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.
    Rezaei N, Arandi N, Valibeigi B, Haghpanah S, Khansalar M, Ramzi M.
    Turk J Haematol; 2017 Dec 01; 34(4):300-306. PubMed ID: 28294102
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H.
    Hum Pathol; 2013 Oct 01; 44(10):2038-46. PubMed ID: 23701943
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia.
    Perry M, Bertoli S, Rocher C, Hayette S, Ducastelle S, Barraco F, Labussière-Wallet H, Salles G, Recher C, Thomas X, Paubelle E.
    Clin Lymphoma Myeloma Leuk; 2018 Dec 01; 18(12):e545-e550. PubMed ID: 30082225
    [Abstract] [Full Text] [Related]

  • 19. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.
    Mason EF, Hasserjian RP, Aggarwal N, Seegmiller AC, Pozdnyakova O.
    Blood Adv; 2019 Nov 12; 3(21):3322-3332. PubMed ID: 31698462
    [Abstract] [Full Text] [Related]

  • 20. Association of cup-like nuclei in blasts with FLT3 and NPM1 mutations in acute myeloid leukemia.
    Park BG, Chi HS, Jang S, Park CJ, Kim DY, Lee JH, Lee JH, Lee KH.
    Ann Hematol; 2013 Apr 12; 92(4):451-7. PubMed ID: 23238897
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.